ITB No. 2024-0042-CSL || Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Chromatographs complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Cebu and Davao Testing and Quality Assurance Laboratories (CTQAL and DTQAL)
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Chromatographs complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Cebu and […]
ITB No. 2024-0041-CSL || Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Spectrophotometers complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang and Cebu Testing and Quality Assurance Laboratories (ATQAL and CTQAL)
Project Descriptions Bid Bulletins/Issuances/ Announcements/Remarks Status Supply, Delivery, Installation, Commissioning, And Testing of Brand-New Spectrophotometers complete with all necessary parts and accessories for Common Services Laboratory (CSL) – Alabang and […]
Featured Activity || Cascading of FDA-Related Laws, Rules, and Regulations
In a two-day Cascading of FDA-related laws, rules and regulations initiated by the Policy and Planning Service (PPS), respective lawyers of the Legal Services Support Center (LSSC) discussed various laws, […]
FDA Advisory No.2024-0543 || ON-BOARDING OF THE LICENSING PROCEDURES FOR HOUSEHOLD/URBAN HAZARDOUS SUBSTANCES (HUHS) ESTABLISHMENTS ON THE FOOD AND DRUG ADMINISTRATION (FDA) ESERVICES PORTAL SYSTEM
The Food and Drug Administration (FDA) continues its digital system enhancement through the development of online application platforms, particularly, the FDA eServices Portal System. These enhancements aim to further simplify […]
FDA Advisory No.2024-0542 || Resumption of the Conduct of Foreign GMP Inspection
Following the declaration of the World Health Organization (WHO), stating that COVID-19 no longer constitutes a public health emergency of international concern, and the lifting of the State of Public […]
FDA Advisory No.2024-0539 || Full Implementation of FDA Circular No. 2021-021 Entitled “Guidelines on the Licensing of Retailers of Medical Devices in the Philippines”
On 7 October 2021, FDA Circular (FC) No. 2021-021 was issued to provide specific guidelines on the licensing of retailers of medical devices supplementing the provisions of Department of Health […]
FDA Advisory No.2024-0536-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:
Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot: 1. OTC KAIXIU Fenghan Ganmao Keli 2. Qian Jiang […]
FDA Advisory No.2024-0536 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:
The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products: 1. OTC KAIXIU® Fenghan Ganmao Keli 2. Qian Jiang Ji […]
FDA Advisory No.2024-0535-A || Babala sa Publiko Tungkol sa Pagbili at Paggamit ng mga Sumusunod na Hindi Rehistradong Gamot:
Pinapayuhan ng Food and Drug Administration (FDA) ang publiko laban sa pagbili at paggamit ng mga sumusunod na hindi rehistradong gamot: 1. NSAIDs Dexirofen (Dexibuprofen) Tablet 2. Saxenda® 3mL x […]
FDA Advisory No.2024-0535 || Public Health Warning Against the Purchase and Use of the Following Unregistered Drug Products:
The Food and Drug Administration (FDA) advises the public against the purchase and use of the following unregistered drug products: 1. NSAIDs Dexirofen (Dexibuprofen) Tablet 2. Saxenda® 3mL x 5 […]